Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Prurigo

• A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
• Benralizumab in Chronic Prurigo - Investigating Clinical Efficacy (BICPIC)
• A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis
• A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis
• Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin
• A Study of CDX-0159 in Patients With Prurigo Nodularis
• A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
• An Efficacy and Safety Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis
• A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)
• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable
• Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis
• Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
• Pain Outcomes Following Intralesional Corticosteroid Injections
• Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis
• Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
• Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
• PRISM Study-Pruritus Relief Through Itch Scratch Modulation
• Safety and Efficacy of Nemolizumab in PN
• A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)
• Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
• Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
• Topical Aprepitant in Prurigo Patients
• Dapsone Prurigo Study
• Safety and Efficacy of CC-10004 for Prurigo Nodularis
• Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis
• Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease